Phase 2b Study (pregnant women): RSVpreF vaccine elicited neutralizing antibody responses with efficient transplacental transfer and without evident safety concerns. MODERNA:mRNA-1777, mRNA-1172, mRNA-1345 Moderna 是目前唯一一个布局 RSV 疫苗且快速进展到临床 2/3 期的 mRNA 疫苗厂商。但实际上其 RSV ...
换句话说，目前这些个 III 期临床的 RSV Vaccine Candidates，哪些可能更可能在未来2025年左右顺利上市，...
Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 ResultsMeara, KillianPatient Care (Online)
June 11, US Innorna, a clinical-stage biotech company pioneering its proprietary lipid nanoparticle (LNP) technology to develop novel mRNA vaccines and therapeutics, is thrilled to announce a significant regulatory milestone. Its first-in-class bivalent Respiratory Syncytial Virus (RSV) mRNA vaccine, ...
$Moderna(MRNA)$RSV vaccine sales were $10 million in the quarter. 全部讨论 HakunaMatata鞋套 该公司第三季度的收入还包括其 RSV 疫苗在美国的 1000 万美元销售额,该疫苗于 5 月获得批准。Moderna 表示,该疫苗的销售额低于预期,因为它在合同季节晚些时候获得了监管机构的批准和推荐,当时许多疫苗分销商已经完...
which greatly improve the mRNA vaccine’s accessibility. JCXH-108 mRNA encodes an engineered RSV Fusion protein with stabilized pre-fusion configuration (pre-F). The antigen design went through extensive screening and optimization and is proprietary for Immorna. In preclinical studies, the pre-F an...
19 The ongoing, randomized, double-blind, placebo-controlled study is evaluating the safety and efficacy of the mRNA-1345 vaccine against RSV-associated lower respiratory tract illness (LRTI). Top-line results showed the efficacy of the vaccine to be 83.7% (95.88% CI, 66.1%-92.2%; P < ....
which greatly improve the mRNA vaccine’s accessibility. JCXH-108 mRNA encodes an engineered RSV Fusion protein with stabilized pre-fusion configuration (pre-F). The antigen design went through extensive screening and optimization and is proprietary for Immorna. In preclinical studies, the pre-F an...
The present invention relates to an mRNA sequence, comprising a coding region, encoding at least one antigenic peptide or protein of RSV infections Respiratory syncytial virus (RSV)
The present invention relates to an mRNA sequence, comprising a coding region, encoding at least one antigenic peptide or protein of RSV infections Respiratory syncytial virus (RSV)